S

Soleno Therapeutics
D

SLNO

71.640
USD
-5.71
(-7.38%)
مغلق
حجم التداول
442,475
الربح لكل سهم
-3
العائد الربحي
-
P/E
-17
حجم السوق
3,807,308,445
أصول ذات صلة
ABBV
ABBV
2.030
(0.99%)
206.710 USD
ALNY
ALNY
6.65
(1.50%)
449.19 USD
C
CRMD
0.315
(2.50%)
12.920 USD
G
GLPG
0.650
(2.05%)
32.420 USD
GSK
GSK
0.105
(0.27%)
39.325 USD
MRK
MRK
1.500
(1.81%)
84.250 USD
PFE
PFE
0.055
(0.22%)
25.155 USD
T
TTNP
0.11000
(2.29%)
4.92000 USD
المزيد
الأخبار المقالات

العنوان: Soleno Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulationof a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.